Dr. Jeannine Villella, DO
Claim this profileLenox Hill Hospital
Affiliated Hospitals
Lenox Hill Hospital
Northwell Heatlh/Lenox Hill Hospital
Clinical Trials Jeannine Villella, DO is currently running
TILT-123 + Pembrolizumab
for Ovarian Cancer
This is an open-label, phase 1/1b, dose-escalation, multicenter and multinational trial evaluating the safety of oncolytic adenovirus TILT-123 in combination with Pembrolizumab, or Pembrolizumab and Pegylated Liposomal Doxorubicin in patients with platinum resistant or refractory ovarian cancer.
Recruiting
1 award
Phase 1 & 2
10 criteria
NavDx(R) Blood Test
for Gynecologic Cancers
Human papilloma virus-related gynecologic malignancies affect over 20,000 women in the United States, and over half a million women globally each year. In addition, approximately 200,000 women are diagnosed with high-grade cervical dysplasia, a pre-cancerous tumor. There is no currently available serum biomarker for these tumors, and surveillance and diagnosis in these patients often requires invasive testing and procedures. The ability to diagnose and monitor for these cancers with a simple blood draw would have a significant impact both here in the US and abroad. In order to detect circulating tumor-specific HPV DNA, the investigators will collaborate with the molecular diagnostics company, Naveris. Naveris has designed a blood test that utilizes digital droplet polymerase chain reactions (PCR) in order to quantify fragments of tumor-specific DNA that the investigators believe is shed by HPV-associated cancer cells in the blood. In this pilot study, the investigators will first test whether the quantification of plasma cell-free HPV DNA can distinguish pre-invasive from invasive cervical cancers.
Recruiting
1 award
N/A
More about Jeannine Villella, DO
Clinical Trial Related
3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jeannine Villella, DO has experience with
- NavDx(R)
- Pembrolizumab
- TILT-123
Breakdown of trials Jeannine Villella, DO has run
Cervical Dysplasia
Cervical Cancer
Acute Viral Infection
Peritoneal Carcinoma
Fallopian Tube Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeannine Villella, DO specialize in?
Jeannine Villella, DO focuses on Cervical Dysplasia and Cervical Cancer. In particular, much of their work with Cervical Dysplasia has involved treating patients, or patients who are undergoing treatment.
Is Jeannine Villella, DO currently recruiting for clinical trials?
Yes, Jeannine Villella, DO is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Jeannine Villella, DO has studied deeply?
Yes, Jeannine Villella, DO has studied treatments such as NavDx(R), Pembrolizumab, TILT-123.
What is the best way to schedule an appointment with Jeannine Villella, DO?
Apply for one of the trials that Jeannine Villella, DO is conducting.
What is the office address of Jeannine Villella, DO?
The office of Jeannine Villella, DO is located at: Lenox Hill Hospital, New York, New York 10075 United States. This is the address for their practice at the Lenox Hill Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.